Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$23.8M
-18.6% from 2023
Prescriptions
5,152
$4,622.17 per claim
Patients
679
502 prescribers
Total spending, 2024
$23.8M
$35,037.21 per patient
Medicare prescription drug plans paid $23.8M for Adcirca in 2024, for 5,152 prescriptions and refills to 679 patients (down 18.6% from 2023). The average cost per claim was $4,622.17.
California had the highest Medicare cost for Adcirca in 2024: $2.8M for 624 claims, followed by New York ($2.3M).
Shelley M Shapiro, cardiology in Los Angeles, CA, had the highest Medicare cost for Adcirca in 2024: 107 claims costing $543K.
Adcirca is made by Eli Lilly and Company (LLY), listed in the Medicare spending data as Eli Lilly & Co..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Shelley M Shapiro Los Angeles, CA | Cardiology | 107 | 15 | $543K |
| Zeenat Safdar Houston, TX | Pulmonary Disease | 49 | Under 11 | $374K |
| Frank Cefali New York, NY |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 625 | 7,161 | 906 | $33.5M |
| 2023 | 563 | 6,144 | 801 | $29.3M |
| 2024 | 502 | 5,152 | 679 | $23.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Nurse Practitioner |
| 97 |
| 14 |
| $357K |
| Christina M Eagan Gainesville, FL | Nurse Practitioner | 85 | 12 | $348K |
| Hubert J Ford III Chapel Hill, NC | Pulmonary Disease | 82 | Under 11 | $346K |
| Naomi G Habib Phoenix, AZ | Pulmonary Disease | 74 | Under 11 | $309K |
| Scarlett H Harden Dallas, TX | Nurse Practitioner | 62 | Under 11 | $299K |
| Akshay Muralidhar Scottsdale, AZ | Critical Care (Intensivists) | 60 | Under 11 | $272K |
| Lori G Reed Marietta, GA | Nurse Practitioner | 48 | Under 11 | $242K |
| Murali M Chakinala Saint Louis, MO | Pulmonary Disease | 48 | Under 11 | $237K |
| Ricardo Restrepo-Jaramillo Tampa, FL | Pulmonary Disease | 24 | Under 11 | $210K |
| Jose Tallaj Birmingham, AL | Advanced Heart Failure and Transplant Cardiology | 52 | Under 11 | $209K |
| Chad Miller Austell, GA | Pulmonary Disease | 38 | Under 11 | $209K |
| Mary Whittenhall Attleboro, MA | Nurse Practitioner | 54 | Under 11 | $205K |
| Timothy L Williamson Kansas City, KS | Pulmonary Disease | 31 | Under 11 | $197K |
| Christina Migliore Newark, NJ | Internal Medicine | 41 | Under 11 | $194K |
| Lesha R McPeak San Francisco, CA | Nurse Practitioner | 46 | Under 11 | $183K |
| Varsha S Taskar Augusta, GA | Pulmonary Disease | 44 | Under 11 | $179K |
| Kerri A Smith Philadelphia, PA | Critical Care (Intensivists) | 42 | Under 11 | $177K |
| Rajan Saggar Los Angeles, CA | Pulmonary Disease | 29 | Under 11 | $168K |
| R J White Rochester, NY | Pulmonary Disease | 39 | Under 11 | $163K |
| Neal F Chaisson Cleveland, OH | Pulmonary Disease | 45 | Under 11 | $158K |
| Daniela Brady New York, NY | Nurse Practitioner | 39 | Under 11 | $154K |
| John W McConnell Louisville, KY | Pulmonary Disease | 38 | Under 11 | $154K |
| Eric G Roberts Milwaukee, WI | Advanced Heart Failure and Transplant Cardiology | 30 | Under 11 | $152K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Eli Lilly & Co. LLY | 5,153 | $23.8M |